A double-blind, randomised, multicenter, comparative study of escitalopram and duloxetine in outpatients with Major Depressive Disorder
Latest Information Update: 28 Dec 2021
At a glance
- Drugs Escitalopram (Primary) ; Duloxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
Most Recent Events
- 30 Aug 2021 This trial has been completed in Spain (End Date: 12 Sep 2006), according to European Clinical Trials Database record.
- 06 Sep 2019 New trial record